The gut microbiome, mild cognitive impairment, and probiotics: A randomized clinical trial in middle-aged and older adults

Coming Soon.

Year: 2022

Reference: Aljumaah, M. R., Bhatia, U., Roach, J., Gunstad, J., & Azcarate Peril, M. A. (2022). The gut microbiome, mild cognitive impairment, and probiotics: A randomized clinical trial in middle-aged and older adults. Clinical nutrition (Edinburgh, Scotland), 41(11), 2565–2576. https://doi.org/10.1016/j.clnu.2022.09.012

Related Studies

High-fat diet, microbiome-gut-brain axis signaling, and anxiety-like behavior in male rats

Obesity, linked with high-fat diet (HFD) consumption, and anxiety are prevalent in modern urban societies. According to recent studies, the association between HFD and anxiety may be mediated via the microbiota-gut-brain axis, specifically involving brain serotonergic systems. There is evidence that this link is mostly due to interactions between the gut bacteria and the serotonergic […]

The role of the brain-gut-microbiota axis in psychology: The importance of considering gut microbiota in the development, perpetuation, and treatment of psychological disorders

Since the prevalence of psychological disorders are not decreasing despite the rise in pharmacological treatments, Ganci et al. (2019) aimed to enhance their understanding of the precise role of gut microbiota (GM) in psychological illness (since it represents an attractive target for novel interventions) by closely examining the relevant literature. This paper found that gut […]